Keytruda 100mg – How It Helps Treat Multiple Advanced Cancers

0

Introduction

Keytruda 100mg Injection can Treat Multiple Cancers. Multiple advanced cancers can refer to having one or more primary cancers at the same time or a single cancer that has spread to multiple other parts of the body, termed metastatic cancer. Treating this type of cancer is unlikely, even if it is confined to one place.

Why Immunotherapy Matters

Immunotherapy activates the body’s own immune system to identify and kill the cancer cells. It is also used for the patients whose cancers are resistant to traditional treatments like radiation and chemotherapy. It provides long-term protection against cancer.

What Is Keytruda 100 mg Injection?

Keytruda Injection is a form of cancer immunotherapy that is used for the treatment of a wide variety of cancers. It comes under the immunotherapy class of category for treating multiple cancers. It is a prescription-based medicine.

How Keytruda Works

Keytruda 100mg Injection targets the immune cells such as T-cells or the programmed death receptor-1 (PD-1). It consists of monoclonal antibodies. Cancer cells often escape from the immune system by producing proteins such as PD-L1 and PD-L2, which bind to the T-cell’s PD-1 receptors and inactivate them. This injection blocks the interaction and allows T-cells to identify and destroy cancer cells.

  • Identify cancer cells more accurately.
  • Boost the immune system’s ability to fight off cancers.
  • Reduce or inhibit the spread of cancer.

Cancers Treated With Keytruda

Keytruda can be used in combination with other medicines to treat a broad range of cancers, such as:

  • Non-small cell lung cancer (NSCLC)
  • Classical Hodgkin lymphoma
  • Stomach (gastric) and esophageal cancer
  • Kidney (renal cell) carcinoma
  • Melanoma (skin cancer)
  • Head and neck squamous cell cancer
  • Bladder cancer
  • Cervical cancer
  • Colorectal cancer 

Dosage and Administration

The dosage and duration of the medicine depend on the type and stage of cancer. This medication is colorless to slightly yellow. It is supplied in a vial containing 100 mg of pembrolizumab in 4 ml of solution. It is given intravenously over 30 minutes; it is not to be self-administered.

Common Side Effects

The injection can cause the following side effects:

  • Pain (bones). Joints or muscles)
  • Fever
  • Tiredness
  • Skin rashes (redness and itching)
  • Headache
  • Thyroid problems

Precautions and Warnings

  • The risk of infection gets increased, such as sepsis and pneumonia, and the risk of bleeding and bruising.
  • Heart problems like chest pain, blood thinners, and heart palpitations can occur.
  • The chance of drug interaction is possible.
  • It is advised to not take the tablet while breastfeeding or pregnant.
  • Patients having chronic diseases are not advised to take this medicine.

Read More – Lumakras 120mg Tablet for Non-Small Cell Lung Cancer

Leave A Reply

Your email address will not be published.